Ptc Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
PTCT on Nasdaq
Industry
Pharmaceutical Preparations
Location
500 Warren Corporate Center Drive, Warren, NJ

Insiders trading volume in the past year

Ptc Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Matthew B. Klein CHIEF EXECUTIVE OFFICER, Director $18.6M -$968K -4.96% Feb 19, 2025
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER, Director $10.9M Jan 31, 2023
Neil Gregory Almstead Chief Technical Ops Officer $6.61M -$4.01M -37.8% Feb 19, 2025
Michael Schmertzler Director $6.4M Jan 3, 2025
Eric Pauwels Chief Business Officer $5.72M -$945K -14.2% Mar 14, 2025
Mark Elliott Boulding Exec. Vp And Clo $5.53M -$10.2M -64.8% Mar 12, 2025
Pierre Gravier Chief Financial Officer $5.25M -$194K -3.57% Feb 19, 2025
Lee Scott Golden Evp & Chief Medical Officer $4.92M -$226K -4.39% Apr 2, 2025
Christine Marie Utter Svp, Chief Accounting Officer $4.08M -$1.14M -21.9% Feb 19, 2025
Emily Luisa Hill Chief Financial Officer $2.22M Mar 27, 2023
Allan Steven Jacobson Director $1.22M -$63.4K -4.93% Mar 4, 2025
Dawn Svoronos Director $1.12M Jun 9, 2022
Jerome B. Zeldis Director $1.07M -$2M -65.1% Jan 3, 2025
David P. Southwell Director $1.07M Jan 3, 2025
Glenn Jr Steele Director $1.07M Jan 3, 2025
Mary L. Smith Director $1.04M Jan 3, 2025
Alethia Young Director $1.01M Jan 3, 2025
Emma Reeve Director $924K Jan 3, 2025
Stephanie Okey Director $717K -$270K -27.4% Mar 13, 2025
William F. Bell Jr. Director $552K Feb 15, 2024

Recent Insider Transactions by Companies or Individuals for Ptc Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.